Effect of a dopamine agonist on luteinizing hormone receptors, cyclic AMP production and steroidogenesis in rat Leydig cells

Toxicology and Applied Pharmacology

Volumn 150, Issue 2, 1998, Pages 393-401

  Dirami, Ghenima ^a   Cooke, Brian A ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

cAMP; CU32 085; Dopamine agonist; Leydig cell hyperplasia; LH receptors; Mesulergine; Pregnenolone; Testosterone

Indexed keywords

22 HYDROXYCHOLESTEROL; BUCLADESINE; CU 327085; CYCLIC AMP; DOPAMINE RECEPTOR STIMULATING AGENT; LUTEINIZING HORMONE RECEPTOR; MESULERGINE; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DENSITY GRADIENT CENTRIFUGATION; IN VITRO STUDY; LEYDIG CELL; LUTEINIZING HORMONE RELEASE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION; STEROIDOGENESIS;

ANIMALIA;

EID: 0032102416     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8429     Document Type: Article

References (55)

1. Abney T. O., Melner C. M. H. Characterization of estrogen binding and the developing rat testism ontogeny of the testicular cytoplasmic estrogen receptor. Steroids. 34:1979;413-427.
2. Adams E. F., Coldham N. G., James V. H. Steroidal regulation of oestradiol-17 beta dehydrogenase activity of the human breast cancer cell line MCF-7. J. Endocrinol. 118:1988;149-154.
3. Bambino T. H., Hsueh A. J. W. Direct inhibitory effect of glucocorticoids upon testicular luteinizing hormone receptor and steroidogenesis in vivo and in vitro. Endocrinology. 108:1981;2142-2148.
4. Bartke A., Sweeney C. A., Johnson L., Castracane V. D., Doherty P. C. Hyperprolactinemia inhibits development of Leydig cell tumors in aging Fischer rats. Exp. Aging Res. 11:1985;123-127.
5. Biegel L. B., Liu R. C. M., Hurtt M. E., Cook J. C. Effects of ammonium perfluorooctanoate on Leydig cell function:In vitro, in vivo,ex vivo. Toxicol. Appl. Pharmacol. 134:1995;18-25.
6. Brinkmann A. O., Leemborg F. G., Roodnat E. M., de Jong F. E., van der Molen H. J. A specific action of estradiol on enzymes involved in testicular steroidogenesis. Biol. Reprod. 23:1980;801-809.
7. Brown C. E., Warren S., Chute R. N., Ryan K. J., Todd R. B. Hormonally induced tumors of the reproductive system of parabiosed male rats. Cancer Res. 39:1979;3971-3975.
8. Carter D. A., Whitehead S. A. Pituitary sensitivity to gonadotrophin releasing hormone after hyperprolactinaemia induced with neuroleptics and domperidone in the rat. J. Endocrinol. 91:1981;439-446.
9. Catt K. J., Harwood J. P., Aguilera G., Dufau M. L. Hormonal regulation of peptide receptors and target cell responses. Nature. 280:1979;109-116.
10. Chan V., Katikineni M., Davies T. F., Catt K. J. Hormonal regulation of testicular luteinizing hormone and prolactin receptors. Endocrinology. 108:1981;1607-1612.
11. Chasalon F. Mechanism and control of rat testicular steroid synthesis. Cytosol stimulation of steroidogenesis. J. Biol. Chem. 254:1979;3000-3005.
12. Chatani F., Nonoyama T., Sudo K., Miyajima H., Takeyama M., Takatsuka D., Mori H., Matsumoto K. Stimulatory effect of luteinizing hormone on the development and maintenance of 5 alpha-reduced steroid-producing testicular interstitial cell tumors in Fischer 344 rats. Anticancer Res. 10:1990;337-342.
13. Cheung C. Y. Prolactin suppresses luteinizing hormone secretion and pituitary responsiveness to luteinizing hormone-releasing hormone by a direct action at the anterior pituitary. Endocrinology. 113:1983;632-638.
14. Choi M. S. K., Cooke B. A. Calmidazolium is a potent stimulator of steroidogenesis via mechanisms not involving cyclic AMP, calcium or protein synthesis. Biochem. J. 281:1992;291-296.
15. Christensen A. K., Peacock K. C. Increase in Leydig cell number in testes of adult rats treated chronically with an excess of hCG. Biol. Reprod. 22:1980;383-391.
16. Cigorraga S. B., Dufau M. L., Catt K. J. Regulation of luteinizing hormone receptors and steroidogenesis in gonadotropin-desensitized leydig cells. J. Biol. Chem. 253:1978;4297-4304.
17. Cigorraga S. B., Sorrell S., Bator J., Catt K. J., Dufau M. L. Estrogen dependence of a gonadotropin-induced steroidogenic lesion in rat testicular Leydig cells. J. Clin. Invest. 65:1980;699-705.
18. Clausen O. P. F., Purvis K., Hansson V. Age related changes in (125I)hLH specific binding to rat interstitial cells. Acta Endocrinol. Copenh. 96:1981;569-576.
19. Clegg E. D., Cook J. C., Chapin R. E., Foster P. M., Daston G. P. Leydig cell hyperplasia and adenoma formation: Mechanisms and relevance to humans. [Review]. Reprod. Toxicol. 11:1997;107-121.
20. Cook J. C., Mullin L. S., Frame S. R., Biegel L. B. Investigation of a mechanism for Leydig cell tumorigenesis by linuron in rats. Toxicol. Appl. Pharmacol. 119:1993;195-204.
21. Cook J. C., Murray S. M., Frame S. R., Hurtt M. E. Induction of Leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 113:1992;209-217.
22. Cooke B. A., Dirami G., Chaudry L., Choi M. S. K., Abayasekara D. R. E., Phipp L. Release of arachidonic acid and the effects of corticosteroids on steroidogenesis in rat testis Leydig cells. J. Steroid Biochem. Mol. Biol. 40:1991;465-471.
23. Dirami G., Poulter L. W., Cooke B. A. Separation and characterization of Leydig cells and macrophages from rat testes. J. Endocrinol. 130:1991;357-365.
24. Dirami G., Teerds K. J., Cooke B. A. Effect of a dopamine agonist on the development of Leydig cell hyperplasia in Sprague Dawley rats. Toxicol. Appl. Pharmacol. 141:1996;169-177.
25. Dufau M. L., Cigorraga S., Baukal A. J., Serrell S., Bator J. M., Neubauer J. F., Catt K. J. Androgen biosynthesis in Leydig cells after testicular desensitization by LHRH and hCG. Endocrinology. 105:1979;1314-1321.
26. Freeman D. A., Ascoli M. Desensitization to gonadotropins in cultured Leydig tumor cells involves loss of gonadotropin receptors and decreased capacity for steroidogenesis. Proc. Natl. Acad. Sci. USA. 78:1981;6309-6313.
27. Hodson C. A., Simpkins J. W., Pass K. A., Aylsworth C. F., Steger R. W., Meiters J. Effects of a prolactin-secreting pituitary tumor on hypothalamic, gonadotropic and testicular function in male rats. Neuroendocrinology. 30:1980;7-10.
28. Hosokawa S., Murakami M., Ineyama M., Yamada T., Yoshitake A., Yamada H., Miyamoto J. The affinity of procymidone to androgen receptor in rats and mice. J. Toxicol. Sci. 18:1993;83-93.
29. Klemcke H. G., Bartke A. Effects of chronic hyperprolactinemia in mice on plasma gonadotropin concentrations and testicular human chorionic gonadotropin binding sites. Endocrinology. 108:1981;1763-1768.
30. Maddocks S., Setchell B. P. Effect of a single injection of human chorionic gonadotrophin on testosterone levels in testicular interstitial fluid, and in testicular and peripheral venous blood in adult rats. J. Endocrinol. 121:1989;311-316.
31. Moger W. H. In vitro inhibitory effect of estradiol on testosterone production. J. Steroid Biochem. 13:1980;61-66.
32. Monder C. Corticosteroids, receptors, and the organ specific functions of 11β-hydroxysteroid dehydrogenase. FASEB J. 5:1991;3047-3054.
33. Mulder E., Brinkman A. O., Lamers-Stahlhofen G. J., van der Molen H. J. Binding of oestradiol by the nuclear fraction of rat testis interstitial tissue. FEBS Lett. 31:1973;131-136.
34. Nozu K., Dufau M. L., Catt H. J. Estradiol receptor mediated regulation of steroidogenesis in gonadotropin desensitized Leydig cells. J. Biol. Chem. 256:1981;1915-1922.
35. Orczyk G. P., Mordes J. P., Longcope C. Aromatase activity in a rat Leydig cell tumor. Endocrinology. 120:1987;1482-1489.
36. Pasanen M. Human placental aromatase activity: Use of a C18 reversed phase cartridge for separation of tritiated water or steroid metabolites in placentas from both smoking and non-smoking mothers in vitro. Biol. Res. Pregnancy. 6:1985;94-99.
37. Pomerantz D. K. Human chorionic gonadotropin enhances the ability of gonadotropic hormones to stimulate aromatization in the testis of the rat. Endocrinology. 109:1981;2004-2008.
38. Prentice D. E., Meikle A. W. A review of drug-induced leydig cell hyperplasia and neoplasia in the rat and some comparisons with man. Hum. Exp. Toxicol. 14:1995;562-572.
39. Prentice D. E., Siegel R. A., Donatsch P., Qureshi S., Ettlin R. A. Mesulergine induced Leydig cell tumours, a syndrome involv-ing the pituitary-testicular axis of the rat. Arch. Toxicol. Suppl. 15:1992;197-204.
40. Purvis K., Cusan L., Hansson V. Regulation of steroidogenesis and steroid action in Leydig cells. [Review] [105 refs]. J. Steroid Biochem. 15:1981;77-86.
41. Rommerts F. F. G., Cooke B. A., van der Kemp J. W. C. M., van der Molen H. J. Stimulation of 3′5′-cyclic AMP and testosterone production in rat testis in vitro. FEBS Lett. 24:1972;251-254.
42. Ronco A. M., Valladares L. The effect of hCG-induced desensitization on RNA synthesis in rat Leydig cells. Biochem. Int. 27:1992;65-74.
43. Samuels L. T., Uchikawa T., Zain-ul-Abedin M., Huseby R. A. Effect of diethylstilbestrol on enzymes of cryptochid mouse testes of Balb-c mice. Endocrinology. 85:1969;96-102.
44. Sharpe R. M. hCG-induced decrease in availability of rat testis receptors. Nature. 264:1976;644-646.
45. Teerds K. J., de Rooij D. G., de Jong F. H., Rommerts F. F. Rapid development of Leydig cell tumors in a Wistar rat substrain. J. Androl. 12:1991;171-179.
46. Thorell J. I., Johansson B. G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim. Biophys. Acta. 251:1971;363-369.
47. Tsai-Morris C., Knox G. F., Dufau M. L. Gonadotropin induction of a regulatory mechanism of steroidogenesis in fetal Leydig cell cultures. J. Steroid Biochem. 29:1988;285-291.
48. Tsai-Morris C., Knox G., Luna S., Dufau M. L. Acquisition of estradiol-mediated regulatory mechanism of steroidogenesis in cultured fetal rat Leydig cells. J. Biol. Chem. 261:1986;3471-3474.
49. Valladares L. E., Payne A. H. Induction of testicular aromatization by luteinizing hormone in mature rats. Endocrinology. 105:1979;431-436.
50. Viguier-Martinez M. C., Hochereau de Reviers M. T., Barenton B., Perreau C. Endocrinological and histological changes induced by flutamide treatment on the hypothalamo-hypophyseal testicular axis of the adult male rat and their incidences on fertility. Acta Endocrinol. 104:1983a;246-252.
51. Viguier-Martinez M. C., Hochereau de Reviers M. T., Barenton B., Perreau C. Effect of a non-steroidal antiandrogen, flutamide, on the hypothalamo-pituitary axis, genital tract and testis in growing male rats: Endocrinological and histological data. Acta Endocrinol. 102:1983b;299-306.
52. Yamada T., Nakamura J., Murakami M., Okuno Y., Hosokawa S., Matsuo M., Yamada H. The correlation of serum luteinizing hormone levels with the induction of Leydig cell tumors in rats by oxolinic acid. Toxicol. Appl. Pharmacol. 129:1994;146-154.
53. Yamada T., Nakamura J., Murakami M., Okuno Y., Hosokawa S., Matsuo M., Yamada H. Effect of chronic L-dopa administration on serum luteinizing hormone levels in male rats. Toxicology. 97:1995;173-182.
54. Zipf W. B., Payne A. H., Kelch R. P. Prolactin, growth hormone and LH in the maintenance of testicular LH receptors. Endocrinology. 103:1978;595-600.
55. Zylber-Haran E. A., Gershman H., Rosenmann E., Spitz I. M. Gonadotrophin, testosterone and prolactin interrelationships in cadmium-treated rats. J. Endocrinol. 92:1982;123-130.